Copyright
©The Author(s) 2024.
World J Gastrointest Surg. Sep 27, 2024; 16(9): 2942-2952
Published online Sep 27, 2024. doi: 10.4240/wjgs.v16.i9.2942
Published online Sep 27, 2024. doi: 10.4240/wjgs.v16.i9.2942
Table 3 Result of a single sequence prediction model
| | Test group | Training group | ||||
| AUC (95%CI) | Sensitivity (%) | Specificity (%) | AUC (95%CI) | Sensitivity (%) | Specificity (%) | |
| DWI | 0.960 (0.840-1.000) | 80.0 | 100.0 | 0.889 (0.736-1.000) | 88.9 | 66.7 |
| T1WI | 0.812 (0.467-1.000) | 75.0 | 100.0 | 0.864 (0.677-1.000) | 66.7 | 100.0 |
| T2WI fs | 0.710 (0.495-0.894) | 60.0 | 60.0 | 0.828 (0.727-0.917) | 82.6 | 65.2 |
- Citation: Pan GH, Zhou F, Chen WB, Pan ZJ. Advancing gastrointestinal stromal tumor management: The role of imagomics features in precision risk assessment. World J Gastrointest Surg 2024; 16(9): 2942-2952
- URL: https://www.wjgnet.com/1948-9366/full/v16/i9/2942.htm
- DOI: https://dx.doi.org/10.4240/wjgs.v16.i9.2942